Brookstone Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Brookstone Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-90	Closed	-$9K	–	388
2015 Q3	$9K	Buy	90 +86	+2,150%	+$10.2K	﹤0.01%	1191
2015 Q2	$0	Buy	+4	New	+$483	﹤0.01%	2163

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Brookstone Capital Management's FBT Position: Q4 2015 in Review

Brookstone Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2015, closing a stake of 90 shares — an estimated $9K sold.

Brookstone Capital Management first reported a position in FBT in Q2 2015 and held it in 2 quarters. The position peaked at $9K in Q3 2015. 129 funds tracked by Wall St. Rank hold FBT as of Q4 2015.

Brookstone Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2015 after selling out during the quarter.
Brookstone Capital Management sold 90 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2015, an estimated $9K.
Brookstone Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2015 and held it in 2 quarters.
Brookstone Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9K in Q3 2015.
129 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2015.

Based on Brookstone Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.